BF Biosciences gains DRAP's approval for brownfield expansion

MG News | September 09, 2024 at 11:49 AM GMT+05:00

0:00

September 09, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ), has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for its brownfield expansion (Line II).

This expansion includes a pre-filled syringes line, a liquid and lyophilized line, and a product development section.

The commercial production from the pre-filled syringes line has commenced, whereas the liquid & lyophilized line is under internal validation and will start commercial production in the second quarter of FY 2024-25.

Additionally, BF Biosciences Limited has launched Sematide (Semaglutide) in a pre-filled syringe.

Sematide is the first Glucagon-Like Peptide 1 (GLP1) receptor agonist approved for local manufacture in Pakistan, offering a convenient solution for diabetes management.

The pre-filled syringe eliminates dosing errors and is easy to use by the patients.

Sematide is being manufactured at the new state-of-the-art European prefilled syringes line of BF Biosciences Limited.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	159,592.91 216.91M	0.31% 496.12
ALLSHR	97,116.33 768.06M	0.46% 445.03
KSE30	48,297.58 106.33M	0.31% 148.84
KMI30	228,607.02 68.07M	0.59% 1329.76
KMIALLSHR	63,247.23 258.39M	0.62% 387.33
BKTi	44,604.42 43.32M	0.63% 277.31
OGTi	30,819.67 8.30M	0.93% 283.08

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	103,570.00	103,755.00 99,425.00	2360.00 2.33%
BRENT CRUDE	63.70	64.39 63.23	0.32 0.50%
RICHARDS BAY COAL MONTHLY	87.25	0.00 0.00	0.10 0.11%
ROTTERDAM COAL MONTHLY	96.75	96.75 96.75	-0.20 -0.21%
USD RBD PALM OLEIN	1,082.50	1,082.50 1,082.50	0.00 0.00%
CRUDE OIL - WTI	59.80	60.46 59.32	0.37 0.62%
SUGAR #11 WORLD	14.13	14.37 14.07	-0.06 -0.42%